Part 2 intermediary recipient-name field

Editorial approval scope: The team checked current source fidelity, scope boundaries, dates, arithmetic, reader usefulness, practical workflow, and general-information limitations.

Current rule checkpoint

Live 42 CFR 2.24(b)(2) requires the list to provide, for each disclosure, the name or names of the entities to which disclosure was made. Section 2.31 separately identifies the intermediary and the participants or participant class authorized by the general designation. The response should name actual receiving entities rather than a user, route, or platform that merely transported the records.

Name the receiving entity

42 CFR 2.24(b)(2) requires entity names for each disclosure. Use message, interface, release, recipient-directory, and acknowledgment evidence to identify the legal or organizational receiver. Record source name and normalized display name when they differ.

Resolve complex routes

A disclosure may pass through a network, HIE, clearinghouse, vendor, parent organization, facility, or participant. Determine which entity received the records under the general designation and whether multiple entities belong in one entry or separate entries.

Tie the field to consent scope

42 CFR 2.31 supplies special intermediary designation rules. Preserve the intermediary, member participant, treating-provider relationship where applicable, patient, disclosure, recipient, date, information, correction, and evidence link.

Trace the records to the receiving entity

Start with the disclosure event and follow message headers, interface acknowledgments, release records, destination identifiers, participant directories, contracts, routing tables, secure-message receipts, and manual custody evidence. Record the raw source name, stable identifier, legal or organizational entity, facility or site when relevant, and normalized display name.

Do not replace source facts during normalization. Preserve the alias and evidence so another reviewer can reproduce why “North Clinic,” an NPI, and a corporate name were treated as the same or different recipients.

Distinguish intermediary, participant, and transporter

An intermediary may route records to a member participant with a treating-provider relationship under the consent framework. An HIE, network, clearinghouse, hosting vendor, parent company, practice location, individual user, and endpoint can appear in one technical trail. Determine which entity or entities actually received the records under the general designation.

Where a disclosure reaches multiple entities, list each supported receiver. Where a platform holds information only as the intermediary's service provider, document that analysis rather than presenting the platform automatically as the patient-facing recipient.

Resolve organizational change and ambiguity

Track mergers, acquisitions, name changes, practice-group structures, shared inboxes, facility moves, dissolved entities, participant departures, and directory corrections. Display a name the patient can understand while retaining the name and identifier that were true on the disclosure date.

Investigate generic destinations such as “provider,” “network,” “external,” or an unlabeled address. Contact source-system and participant owners through an approved process when evidence is insufficient. Mark and resolve uncertainty before issuing the list.

Keep the name tied to the rest of the entry

For each recipient, link patient, consent, general designation, treating-provider relationship where required, disclosure identifier, date, information description, source system, evidence, correction, and reviewer. Avoid joining a recipient from one event to the date or payload from another because a batch identifier was reused.

Use versioned recipient-master data and retain historical effective periods. Limit manual overrides, require reason and evidence, and review repeated aliases or unknown recipients for interface and directory defects.

Review patient clarity and accuracy

Read the list from the patient's perspective. A correct corporate legal name may still need a familiar facility or practice label to be understandable, while a familiar nickname alone may be ambiguous. Use a consistent presentation approved by privacy and records owners without adding sensitive detail.

Audit entries against source evidence, consent, organizational history, and delivery. Correct both the patient response and the upstream directory or integration when a misnamed recipient is found.

Example

Twenty-two disclosure entries are reviewed. Eighteen have source recipient, normalized entity, consent match, route, evidence, and reviewer; four use a network nickname only. Field completeness is 18 of 22 entries.

Recipient-name checklist

• trace each disclosure through source logs, acknowledgments, directories, and custody evidence;
• retain raw names and identifiers alongside the reviewed display name;
• distinguish intermediary, participant, transporter, vendor, parent, site, and user roles;
• list every actual receiving entity and resolve ambiguous or generic destinations;
• bind the name to consent, date, payload, evidence, corrections, and historical versions; and
• test patient clarity and repair upstream directory or routing errors.

The field should let the patient identify who received the records. Technical routing labels and unsupported normalization cannot meet that purpose.